Medical News

RSS

CVD expert requests Mexican government to carry out mandatory screening for 18-year-olds

A cardiovascular disease expert is calling for mandatory screening of 18 year-old Mexicans to halt the CVD epidemic plaguing the nation. Cardiovascular risk factors will be a key theme at the Mexican Congress of Cardiology, held 23 to 27 November in Leon, Guanajuato, Mexico. The Congress is organised by the Mexican Society of Cardiology and features a collaborative programme with the European Society of Cardiology.

23 Nov 2013

House Speaker Boehner enrolls in Obamacare after initial errors

The Washington Post examines if Sen. Mary Landrieu actually cast the "deciding vote" for the health law as a conservative group is saying she did in an advertising campaign against her. In the meantime, House Speaker John Boehner enrolled Thursday for health coverage through the District of Columbia's online insurance marketplace -- after initially receiving errors.

23 Nov 2013

Sorin Group receives CE Mark approval for Solo Smart stentless aortic valve

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it has received CE Mark approval for the Solo Smart stentless aortic valve.

23 Nov 2013

Financial analysts say in addition to political turmoil, website problems could send stocks into turmoil

Wall Street health care analysts warned Thursday that a failure to successfully launch HealthCare.gov by Nov. 30 could send Democrats fleeing from Obamacare and industry stocks into turmoil. "If the website is not functioning on Nov. 30, then I think you see a stampede of Democratic legislators in risky elections next year," said Carl McDonald, a senior analyst at Citi Investment Research, at a conference organized by the Center for Studying Health System Change (Cheney, 11/21).

23 Nov 2013

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

23 Nov 2013

Consumers shopping on health insurance exchange experience 'sticker shock'

USA Today reports prices may be higher than expected for some middle-class consumers who are not eligible for the health law's subsidies. Meanwhile, Politico highlights how one group -- older Capitol Hill staffers -- is reacting to this marketplace experience.

23 Nov 2013

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has approved OLYSIO (simeprevir), an NS3/4A protease inhibitor, for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with pegylated interferon and ribavirin in genotype 1 infected adults with compensated liver disease, including cirrhosis.

23 Nov 2013

Administration delays 2015 individual plan rate requirements

The change is designed to give insurers more time to compute the costs of individuals who come in late during the plan's first year -- which might avoid higher premiums and steer clear of the 2014 elections.

23 Nov 2013

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Bayer HealthCare and Onyx Pharmaceuticals, Inc., an Amgen subsidiary, today announced that the U.S. Food and Drug Administration has approved a supplemental New Drug Application for the oral multi-kinase inhibitor NEXAVAR (sorafenib) tablets for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment.

23 Nov 2013

Chronic bronchitis could indicate COPD subtype

Chronic bronchitis is common among patients with chronic obstructive disease and may represent a subtype of the disease that places patients at risk for increased severity and exacerbations, say researchers.

22 Nov 2013

Environment plays primary role in psychosis transition

Research suggests that exposure to environmental risk factors may be necessary for individuals at genetically high risk for psychosis to transition from good health to the psychiatric disorder.

22 Nov 2013

Childhood trauma link to bipolar symptoms strengthened

Research confirms a link between childhood trauma and severe symptoms of bipolar disorder in adults.

22 Nov 2013

Vasculitis damage swift, accumulating

Study findings reveal the significant burden of disease among patients with antineutrophil-cytoplasm antibody associated vasculitis, with many individuals showing irreversible damage shortly after diagnosis.

22 Nov 2013

Novel drug combats psychosis in Parkinson’s disease

The non-dopaminergic drug pimavanserin reduces psychotic symptoms in patients with Parkinson’s disease without worsening motor function, shows a randomized trial.

22 Nov 2013

New NPS Direct article reveals that vaccinations fight against antibiotic resistance

During Antibiotic Awareness Week (18-24 November) NPS MedicineWise is urging health professionals to use vaccinations as one important way to limit Australia’s use of antibiotics.

22 Nov 2013

Study highlights need for ongoing surveillance for melanoma survivors

Melanoma survivors are being warned to stay vigilant about skin checks, with new research showing a high risk of a subsequent melanoma diagnosis on the same body part as the original.

22 Nov 2013

New bill offers hope to HIV patients on transplant waiting lists

A bill scheduled to be signed into law today by President Obama reverses the longtime ban on letting HIV-infected people donate their organs for transplantation after death, a move that offers hope to thousands of HIV patients on transplant waiting lists.

22 Nov 2013

First Edition: November 22, 2013

Today's headlines include reports that the Obama administration will push back 2015 Obamacare enrollment by a month, starting Nov. 15, 2014, instead of Oct. 15, 2014.

22 Nov 2013

Patient Safety Technologies announces closing of $5 million senior secured term loan

Patient Safety Technologies, Inc. today announced the closing of a $5 million senior secured term loan. At close, $4 million of the term loan was funded. The Company has the ability to draw an incremental $1 million under the term loan, subject to certain conditions. The five-year term loan matures in 2018 and bears interest at 13% per annum.

22 Nov 2013

Sinai Hospital reports results from Phase 2a trial of apo A-I infusion therapy CSL112

Researchers from the Sinai Center for Thrombosis Research presented findings from a Phase 2a trial substudy that examined the antiplatelet effects of CSL112, a novel apolipoprotein A-I (apo A-I) infusion therapy, at the American Heart Association 2013 Scientific Sessions.

22 Nov 2013